Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism

Background. The purpose of the study is to determine the dynamics of clinical and laboratory characteristics and functional state of peripheral nerves in patients with type 2 diabetes mellitus (DM) complicated by distal symmetrical polyneuropathy (DSPN) depending on the frequency distribution of the...

Full description

Bibliographic Details
Main Authors: I.А. Zoriy, N.V. Pashkovska
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2018-03-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/130555
_version_ 1819280370147786752
author I.А. Zoriy
N.V. Pashkovska
author_facet I.А. Zoriy
N.V. Pashkovska
author_sort I.А. Zoriy
collection DOAJ
description Background. The purpose of the study is to determine the dynamics of clinical and laboratory characteristics and functional state of peripheral nerves in patients with type 2 diabetes mellitus (DM) complicated by distal symmetrical polyneuropathy (DSPN) depending on the frequency distribution of the G894T genotypes of endothelial NO-synthase (eNOS) gene polymorphism during the recommended therapy. Mate­rials and methods. 110 patients were examined, they were divided into groups: with initial manifestations of DSPN — 32 (29.1 %), with moderate course — 58 (52.7 %) and with severe course — 20 (18.2 %). Patients received L-arginine preparation during basic treatment. All patients were neurologically examined using Neuropathic Symptomatic Score, Neuropathic Dysfunctional Score, electroneuromyographic testing of the peripheral nerves of the lower extremities; parameters of carbohydrate metabolism, pro- and antioxidant defense, functional state of the endothelium were evaluated. Results. In patients with DSPN and type 2 DM, homozygotes for the minor T allele of the eNOS gene G894T polymorphism, the likelihood of developing severe complications of diabetic polyneuropathy increases: the odds ratio was 2.91 (95 % confidence interval 1.19–7.14; p < 0.05). In patients with GT and GG genotypes, the highest efficacy of the recommended therapy is determined, in contrast to patients with homozygous TT genotype, whose dynamics of clinical, laboratory and functional indicators was significantly lower. Conclusions. Homozygotes for the minor T allele of the eNOS gene G894T polymorphism have an increase in the incidence and the severity of DSPN course on the background of type 2 DM, and also a less stable effect from the treatment of this complication.
first_indexed 2024-12-24T00:42:43Z
format Article
id doaj.art-b5c1ce619798405e97129ba713c3e19d
institution Directory Open Access Journal
issn 2224-0721
2307-1427
language English
last_indexed 2024-12-24T00:42:43Z
publishDate 2018-03-01
publisher Zaslavsky O.Yu.
record_format Article
series Mìžnarodnij Endokrinologìčnij Žurnal
spelling doaj.art-b5c1ce619798405e97129ba713c3e19d2022-12-21T17:23:54ZengZaslavsky O.Yu.Mìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272018-03-0114212613010.22141/2224-0721.14.2.2018.130555130555Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphismI.А. Zoriy0N.V. Pashkovska1State Higher Education Institution of Ukraine “Bukovinian State Medical University”, Chernivtsi, UkraineState Higher Education Institution of Ukraine “Bukovinian State Medical University”, Chernivtsi, UkraineBackground. The purpose of the study is to determine the dynamics of clinical and laboratory characteristics and functional state of peripheral nerves in patients with type 2 diabetes mellitus (DM) complicated by distal symmetrical polyneuropathy (DSPN) depending on the frequency distribution of the G894T genotypes of endothelial NO-synthase (eNOS) gene polymorphism during the recommended therapy. Mate­rials and methods. 110 patients were examined, they were divided into groups: with initial manifestations of DSPN — 32 (29.1 %), with moderate course — 58 (52.7 %) and with severe course — 20 (18.2 %). Patients received L-arginine preparation during basic treatment. All patients were neurologically examined using Neuropathic Symptomatic Score, Neuropathic Dysfunctional Score, electroneuromyographic testing of the peripheral nerves of the lower extremities; parameters of carbohydrate metabolism, pro- and antioxidant defense, functional state of the endothelium were evaluated. Results. In patients with DSPN and type 2 DM, homozygotes for the minor T allele of the eNOS gene G894T polymorphism, the likelihood of developing severe complications of diabetic polyneuropathy increases: the odds ratio was 2.91 (95 % confidence interval 1.19–7.14; p < 0.05). In patients with GT and GG genotypes, the highest efficacy of the recommended therapy is determined, in contrast to patients with homozygous TT genotype, whose dynamics of clinical, laboratory and functional indicators was significantly lower. Conclusions. Homozygotes for the minor T allele of the eNOS gene G894T polymorphism have an increase in the incidence and the severity of DSPN course on the background of type 2 DM, and also a less stable effect from the treatment of this complication.http://iej.zaslavsky.com.ua/article/view/130555type 2 diabetes mellitusdistal symmetrical polyneuropathyendothelial nitric oxide synthase gene G894T polymorphismL-arginine
spellingShingle I.А. Zoriy
N.V. Pashkovska
Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
Mìžnarodnij Endokrinologìčnij Žurnal
type 2 diabetes mellitus
distal symmetrical polyneuropathy
endothelial nitric oxide synthase gene G894T polymorphism
L-arginine
title Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
title_full Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
title_fullStr Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
title_full_unstemmed Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
title_short Features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene G894T polymorphism
title_sort features of clinical and diagnostic parameters of distal symmetrical polyneuropathy in patients with type 2 diabetes mellitus in the dynamics of treatment depending on the endothelial nitric oxide synthase gene g894t polymorphism
topic type 2 diabetes mellitus
distal symmetrical polyneuropathy
endothelial nitric oxide synthase gene G894T polymorphism
L-arginine
url http://iej.zaslavsky.com.ua/article/view/130555
work_keys_str_mv AT iazoriy featuresofclinicalanddiagnosticparametersofdistalsymmetricalpolyneuropathyinpatientswithtype2diabetesmellitusinthedynamicsoftreatmentdependingontheendothelialnitricoxidesynthasegeneg894tpolymorphism
AT nvpashkovska featuresofclinicalanddiagnosticparametersofdistalsymmetricalpolyneuropathyinpatientswithtype2diabetesmellitusinthedynamicsoftreatmentdependingontheendothelialnitricoxidesynthasegeneg894tpolymorphism